Performance study of cross-linked carboxymethyl rice starch, co-processed with sodium silicate as a direct compression excipient using SeDeM expert system

被引:0
|
作者
Trisopon, Karnkamol [1 ,2 ]
Kittipongpatana, Nisit [1 ,2 ]
Kittipongpatana, Ornanong Suwannapakul [1 ,2 ]
机构
[1] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Sci, Chiang Mai 50200, Thailand
[2] Chiang Mai Univ, Res Ctr Dev Local Lanna Rice & Rice Prod, Chiang Mai 50200, Thailand
关键词
Co-processed excipient; Rice starch; Direct compression; SeDeM expert system; Sodium silicate; Cross-linked carboxymethyl rice starch; PARTICLE-SIZE; MICROCRYSTALLINE CELLULOSE; TABLET STRENGTH; DEFORMATION MECHANISMS; ELASTIC RELAXATION; POWDER COMPACTION; MOISTURE; SILICIFICATION; FUNCTIONALITY; FLOWABILITY;
D O I
10.1016/j.jddst.2023.105056
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This work presents the performance study of cross-linked carboxymethyl rice starch, co-processed with sodium silicate (CXO) as a multifunctional excipient for direct compression (DC). The compression behavior of the powder was investigated, while SeDeM expert system was applied to determine its suitability for the DC process. The results showed that CXO particles highly rearranged during the initial stage of compression. The distortion occurred mainly through plastic deformation with little elastic recovery; thus, promoting excellent compressibility. The small particle size (%Pf) and silicification rendered low lubricant sensitivity. The SeDeM analysis revealed that most incidence factors surpassed the acceptance limit, confirming that CXO was suitable for the DC process. The formulation study suggested that CXO could be diluted with paracetamol up to 54% w/w in the DC formulation. At this ratio, CXO tablets exhibited narrow weight variation (2.3%), low friability (0.42%), and acceptable drug content (101.3%). The moderate disintegration time (5 min) did not limit the tablet dissolution, of which the cumulative drug release was found to surpass 85% within 15 min in all tested media. On the other hand, the formulations containing commercial DC excipients failed to produce DC tablets due to low cumulative drug release and high friability, respectively. These findings indicate the application of CXO as a multifunctional excipient for DC.
引用
收藏
页数:11
相关论文
共 5 条
  • [1] Formulation Study of a Co-Processed, Rice Starch-Based, All-in-One Excipient for Direct Compression Using the SeDeM-ODT Expert System
    Trisopon, Karnkamol
    Kittipongpatana, Nisit
    Wattanaarsakit, Phanphen
    Kittipongpatana, Ornanong Suwannapakul
    PHARMACEUTICALS, 2021, 14 (10)
  • [2] A Spray-Dried, Co-Processed Rice Starch as a Multifunctional Excipient for Direct Compression
    Trisopon, Karnkamol
    Kittipongpatana, Nisit
    Kittipongpatana, Ornanong Suwannapakul
    PHARMACEUTICS, 2020, 12 (06)
  • [3] Development of a Direct Compression Excipient from Epichlorohydrin-Crosslinked Carboxymethyl Rice Starch with Sodium Silicate Using a Coprocessing Technique
    Trisopon, Karnkamol
    Kittipongpatana, Ornanong S.
    STARCH-STARKE, 2019, 71 (5-6):
  • [4] Development and Optimization of a Starch-Based Co-processed Excipient for Direct Compression Using Mixture Design
    Yonni E. Apeji
    Avosuahi R. Oyi
    Adamu B. Isah
    Teryila S. Allagh
    Sameer R. Modi
    Arvind K. Bansal
    AAPS PharmSciTech, 2018, 19 : 866 - 880
  • [5] Development and Optimization of a Starch-Based Co-processed Excipient for Direct Compression Using Mixture Design
    Apeji, Yonni E.
    Oyi, Avosuahi R.
    Isah, Adamu B.
    Allagh, Teryila S.
    Modi, Sameer R.
    Bansal, Arvind K.
    AAPS PHARMSCITECH, 2018, 19 (02): : 866 - 880